| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/27/2002 | US20020081660 Generation of preferential polypeptides; generate reaction mixtures, insert amino acid, recover polypeptides |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081658 Nucleotide sequences coding membrane protein; for use treatment of nervous system disorders, Tourette's syndrome, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, Jakob- Creutzfieldt disease and sleep disorders |
| 06/27/2002 | US20020081657 21784, a novel human calcium channel family member and uses thereof |
| 06/27/2002 | US20020081655 Splice variant of mGluR |
| 06/27/2002 | US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/27/2002 | US20020081652 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis |
| 06/27/2002 | US20020081651 Nucleotide sequences coding enzymatic polypeptide; for us ein the treatment of atherosclerosis, hypertension, oncogenesis and metastasis, heart disease, Alzheimer's disease, neurofibromatosis amd respiratory disorders |
| 06/27/2002 | US20020081650 Expression vectors coding protein for use in the treatment of cancer, and neovascularization defects |
| 06/27/2002 | US20020081649 Peptide for use in human therapeutics and diagnostics; for use as a antitumor agent |
| 06/27/2002 | US20020081648 Peptide for use in human thereapeutics and diagnostics |
| 06/27/2002 | US20020081647 Apoptosis inducing molecule ii and methods of use |
| 06/27/2002 | US20020081640 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 06/27/2002 | US20020081636 Novel molecules of the card-related protein family and uses thereof |
| 06/27/2002 | US20020081634 Detecting preferential enzyme inhibitors; obtain sample containing protease, incubate with amyloid precursor protein, incubate with modulators, compare amount of amyloid precursor protein processing with control |
| 06/27/2002 | US20020081630 Compound for use in the deteCtion of viral infectionS |
| 06/27/2002 | US20020081625 Polynucleotide coding preferential polypeptide for use in mammalian therapeutics and diagnostics |
| 06/27/2002 | US20020081624 Detection of patients at risk for developing integrin antagonist/ agonist mediated disease states |
| 06/27/2002 | US20020081623 Chemotactic cytokine |
| 06/27/2002 | US20020081609 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/27/2002 | US20020081608 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of cancer |
| 06/27/2002 | US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies |
| 06/27/2002 | US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses |
| 06/27/2002 | US20020081604 Polypeptide for use in the treatment of diagnosis, prevention, and treatment of infectious, developmental, neoplastic, and immunological defects |
| 06/27/2002 | US20020081603 Isolating preferential polynucleotide sequences from library; obtain cellular chromatin, incubate with probe, fragment nucleotide sequences, recover marked polynucleotides |
| 06/27/2002 | US20020081602 Detecting modulator of weight control; obtain cells, incubate with modulator, monitor cell resonse to modulator, compare to control |
| 06/27/2002 | US20020081601 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 06/27/2002 | US20020081599 Nucleotide sequences coding preferential polypeptide for use in cancer therapy |
| 06/27/2002 | US20020081592 Reproduction-specific genes |
| 06/27/2002 | US20020081590 Microarray for use in the detection of preferential genes in sample |
| 06/27/2002 | US20020081584 Nucleotide sequences coding preferential polypeptide for use in the diagnosis, prevention and treatment of schizophrenia |
| 06/27/2002 | US20020081579 Detecting nucleotide sequences that code CD4 antigens; obtain cells, transform cells with antigen inducing vector, incubate cells with dendritic cells, determine atigen activation, isolate nucleotide sequences transformed cell |
| 06/27/2002 | US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents |
| 06/27/2002 | US20020081576 Antibodies directed against binding-associated epitopes |
| 06/27/2002 | US20020081574 Enzymatic polypeptide for use in the diagnosis, prevention and treatment of viral disease |
| 06/27/2002 | US20020081568 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
| 06/27/2002 | US20020081566 Hiv protein epitopes immunologically homologous to hla |
| 06/27/2002 | US20020081320 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 06/27/2002 | US20020081318 Protein kinase deficient, immunologically active CMVpp65 mutants |
| 06/27/2002 | US20020081316 Vector and recombinant vaccines made therefrom useful to immunize avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease |
| 06/27/2002 | US20020081312 For the diagnosis and immunization of humans and animals against gastrointestinal disorders |
| 06/27/2002 | US20020081311 Improving gut barrier function and/or competitively excluding pathogens from binding to and invading epithelial cells; adhesin component derived Lactobacillus species such as L. salivarius |
| 06/27/2002 | US20020081310 Apoptosis-related compounds and their use |
| 06/27/2002 | US20020081309 Conjugating a protein with polyethylene glycol (PEG), by deleting amino residue(s); for example, replacing protein arginine residues with lysine residues that provide a PEG attachment site; bioactivity |
| 06/27/2002 | US20020081308 Treatment of Pythium insidiosum infections; animal model for evaluating Pythium insidiosum vaccines |
| 06/27/2002 | US20020081307 Verotoxin b subunit for immunization |
| 06/27/2002 | US20020081306 Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists |
| 06/27/2002 | US20020081304 Type f botulinum toxin and use thereof |
| 06/27/2002 | US20020081302 Peptide or antibody that competitively inhibits binding of CSP (competence signal peptide) to Streptococcus mutans histidine kinase; endocarditis |
| 06/27/2002 | US20020081298 An immunoglobulin or portion thereof linked to a T cell receptor agonist derived from an antigen responsible for an autoimmune disease, capable of undergoing Fc receptor medited ukptake by antigen presenting cells |
| 06/27/2002 | US20020081296 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 06/27/2002 | US20020081295 Virus-like particles for the induction of autoantibodies |
| 06/27/2002 | US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/27/2002 | US20020081285 Treatment for diabetes |
| 06/27/2002 | US20020081283 Immortalizing the hepatocytes by transforming the hepatocytes with a DNA construct comprising a removable DNA segment containing oncogene, growing immortalized hepatocytes, removing oncogene from immortalized hepatocytes |
| 06/27/2002 | US20020081282 Genetically engineered cell comprising DNA encoding a transmembrane LAG-3 protein (lymphocyte activting gene) on its surface resulting in the protection from graft rejection by a host's immune system |
| 06/27/2002 | US20020081280 Virology and gene therapy; modified fiber knob retains its ability to trimerize and retains its native biosynthesis profile |
| 06/27/2002 | US20020081279 In vitro manipulation of a plasmid-cloned chicken embryo lethal orphan (CELO) virus DNA, suitable for the production of vectors for gene therapy and as a vaccine against infectious diseases in human and animals, particularly birds |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2436531A1 Isolation of purified tgf-.beta.1 and tgf-.beta.2 from bone tissue techsource patent |
| 06/27/2002 | CA2433308A1 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432879A1 Anti-allergic complex molecules |
| 06/27/2002 | CA2432785A1 Seleno-cysteine containing protein zsel1 |
| 06/27/2002 | CA2432767A1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | CA2432737A1 Human ion channel protein and polynucleotides encoding the same |
| 06/27/2002 | CA2432506A1 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432301A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/27/2002 | CA2432274A1 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3 |
| 06/27/2002 | CA2432047A1 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | CA2432036A1 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | CA2431964A1 Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| 06/27/2002 | CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2430973A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | CA2430475A1 Methods and cells for detecting modulators of rgs proteins |
| 06/27/2002 | CA2429519A1 Novel human secreted proteins and polynucleotides encoding the same |
| 06/27/2002 | CA2406028A1 Method for testing for allergic disease |
| 06/26/2002 | EP1217616A2 Magnetic composition |
| 06/26/2002 | EP1217072A2 Method of the preparation of an expression vector for the production of therapeutic proteins in transgenic animals |
| 06/26/2002 | EP1217071A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 06/26/2002 | EP1217070A1 Selective cytotoxic fusion proteins |
| 06/26/2002 | EP1217068A2 Oil palm (genus Elaeis) peroxiredoxin gene and uses thereof |
| 06/26/2002 | EP1217067A2 Connective tissue growth factor-2 |
| 06/26/2002 | EP1217066A1 Modulation of ATP-binding cassette transporter activity |
| 06/26/2002 | EP1217007A2 Serum paraoxonase |
| 06/26/2002 | EP1217006A2 Polypeptides and nucleic acids encoding the same |
| 06/26/2002 | EP1217005A1 Synthetic peptide having antitumor cytotoxic activity |
| 06/26/2002 | EP1216714A1 Cellular and serum protein anchors and conjugates |
| 06/26/2002 | EP1216710A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 06/26/2002 | EP1216707A1 New therapeutic uses of a SMR-1-peptide |
| 06/26/2002 | EP1216303A1 Novel detoxified mutants of escherichia coli heat-labile enterotoxin |
| 06/26/2002 | EP1216302A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216301A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216300A1 Methods and compositions relating to sodium channel beta1a subunits |
| 06/26/2002 | EP1216297A2 Double transgenic animals as models for neurodegenerative disease |
| 06/26/2002 | EP1216259A1 SIGNAL SEQUENCES FOR THE PRODUCTION OF LEU-HIRUDINE VIA SECRETION BY i E. COLI /i IN A CULTURE MEDIUM |